LXRX FY 2013 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$729M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+104.0% YoY

Gross Profit

-$87M-3936.1% margin

Operating Income

-$102M-4607.2% margin

Net Income

-$104M-4686.1% margin

EPS (Diluted)

$-1.42

Cash Flow

Operating Cash Flow

-$91M

Free Cash Flow

-$93M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$274M

Total Liabilities

$104M

Stockholders' Equity

-$1.0B

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+104.0%
Gross Profit	-$87M	-$81M	-7.3%
Operating Income	-$102M	-$108M	+5.6%
Net Income	-$104M	-$110M	+5.5%